First and Only Trifocal Cataract Replacement Lens Now Available in the U.S. – Interview

First and Only Trifocal Cataract Replacement Lens Now Available in the U.S. – Interview

Cloudy vision, muted colors, difficulty driving – cataracts can have a major impact on someone’s life. More than 20 million people in the U.S. over the age of 40 have cataracts.1 Vision impairment due to cataracts is a problem many of us have and many more of us will experience. Currently, more than four million cataract surgeries are performed each year in the U.S., and with the aging population, that number is expected to increase by 16% in five years.2,3

There is new hope for cataract sufferers – not only to remove their cataracts — but to restore vision – sometimes resulting in better vision than they have ever had.

The recent, highly anticipated FDA approval of the Alcon AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL) means eye doctors in the U.S. are now able to implant the first and only advanced trifocal lens that makes 20/20 vision at near, intermediate and distance possible, substantially reducing the need for glasses.4,5 With Americans living longer, more active lives and being more optimistic about their future, PanOptix technology is available at an opportune time.

Join me in a recent interview with Robert Cionni, M.D., a world-renowned expert in cataract surgery and a lead PanOptix clinical trial investigator, and patient Barbara Badger as they discussed:

· What are cataracts and how do you know when you are developing them?

· What is an IOL and what is a trifocal IOL?

· What makes PanOptix so revolutionary?

· How many people in the U.S. are estimated to need or benefit from PanOptix®?

See the entire interview here:

For more information, go to

More About Dr. Cionni

Robert J. Cionni, M.D. is the Medical Director of The Eye Institute of Utah and a world-renowned expert in the field of modern cataract surgery. He is a board-certified ophthalmologist, specializing in cataract surgery, lens implants, and refractive surgeries such as LASIKPRKimplantation of ICLs and refractive lens exchange. Dr. Cionni also performs corneal inlay implantation surgery utilizing KAMRA inlays. He has established himself as a leader in his specialty by pioneering some of the most advanced cataract and implant techniques, authoring numerous articles and textbook chapters about specialized cataract techniques, technologies and management of complications. He is actively involved in clinical research bringing the latest technologies to his patients; sometimes, well before these technologies are available to other surgeons.

Dr. Cionni has designed special implants and surgical techniques to improve the surgical outcomes in patients with traumatic cataract and congenital lens subluxation, as found in many patients with Marfan Syndrome. In addition, he teaches surgeons nationally and internationally about the use of these devices. Patients with these types of problems are referred to him from all over the world.

Dr Cionni has become an authority in refractive cataract surgery, helping patients reduce or eliminate their dependency on glasses after cataract surgery. He lectures across the country concerning the use of intraocular lens (IOL) implants such as multifocal presbyopia-correcting IOLs and toric astigmatism correcting implants. In addition to advanced technology IOLs, Dr. Cionni utilizes the LenSx® Femtosecond Laser and ORA System with VerifEye™ to help offer his patients the best, most accurate outcomes with refractive cataract surgery.

Dr. Cionni received degrees in medicine and chemistry from the University of Cincinnati. His academic performance merited election into the Phi Beta Kappa honorary society and while in medical school, he received a Fight for Sight Fellowship Award for his work in corneal wound healing. Following a one-year internship in Internal Medicine at Good Samaritan Hospital in Cincinnati, he traveled to the University of Louisville where he served as a Resident in Ophthalmology. After his Residency, he completed a Fellowship in cataract and implant surgery with Robert H. Osher, M.D. at the Cincinnati Eye Institute.


1.       Prevent Blindness. Vision Problems in the U.S. Report.

2.       Compared to AcrySof®monofocal IOL.

3.       Market Scope. 2017 Ophthalmic Surgical Instrument Report.

4.       AcrySof®IQ PanOptix®Directions For Use.

5.       Compared to AcrySof®monofocal IOL.

Protected by Copyscape

MMN Interview Blogger- Cynthia Tait

Cynthia Tait

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: